Description

The Possible Estuary-Associated Syndrome (PEAS) occurs in humans following exposure to toxic Pfiesteria dinoflagellates. These dinoflagellates have been found in estuarine waters along the Chesapeake Bay and Eastern seaboard and have been associated with fish kills. While the precise toxin has not been identified, a constellation of clinical findings can be used to identify affected individuals.


 

Members of the Toxic Pfiesteria Complex (TPC) include Pfiesteria piscicida and Pfiesteria shumwayae.

 

The CDC criteria for the possible-estuary associated syndrome:

(1) The patient develops symptoms within 2 weeks after exposure to estuarine waters.

(2) The patient develops:

(2a) memory loss or confusion of any duration, OR

(2b) 3 or more of the following symptoms for >= 2 weeks: burning skin, eye irritation, upper respiratory irritation, muscle cramps, and gastrointestinal symptoms.

(3) A health care provider cannot identify another cause for the symptoms.

 

where:

• Exposure may consist of (a) swimming or other skin contact with water, (b) drinking contaminated water, (c) exposure to affected fish, or (d) inhalation of aerosolized or volatilized toxins.

• The onset of acute illness may be 24-36 hours after the exposure.

• A skin rash may develop at the site of skin contact with water.

• The sensation of burning skin may be noted shortly after touching the water. It may not persist for >= 2 weeks.

• Gastrointestinal symptoms include secretory diarrhea, abdominal pain and anorexia.

• Patients may also note: weight loss, sensitivity to bright lights, fatigue, muscle aches, lethargy, vertigo, shortness of breath and cough.

• The patient may have noted a large number of diseased, dying or dead fish.

• Untreated the disorder may become chronic and last for 6 or more months.

• A patient treated for PEAS syndrome may have symptoms resolve before 2 weeks have passed.

 

Demonstration of a sharp reduction in visual contrast sensitivity (VCS) provides an objective finding for PEAS. This measures the patient's ability to detect visual patterns.

 

Standard treatment protocol for PEAS:

(1) cholestyramine

(2) sorbitol, 70% solution

(3) Prilosec

 


To read more or access our algorithms and calculators, please log in or register.